# Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

> **NCT00491855** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Peritoneal Cancer

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Oxaliplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00491855
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00491855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00491855, "Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00491855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*